Hodgkin's lymphoma as a second cancer in multiple myeloma never exposed to lenalidomide.
about
Lenalidomide, Thalidomide, and Pomalidomide Reactivate the Epstein-Barr Virus Lytic Cycle through Phosphoinositide 3-Kinase Signaling and Ikaros Expression.EBV-positive Diffuse Large B-cell Lymphoma as a Secondary Malignancy Arising in a Myelodysplastic Syndrome Patient who Was Treated with Azacitidine.
P2860
Hodgkin's lymphoma as a second cancer in multiple myeloma never exposed to lenalidomide.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Hodgkin's lymphoma as a second cancer in multiple myeloma never exposed to lenalidomide.
@en
Hodgkin's lymphoma as a second cancer in multiple myeloma never exposed to lenalidomide.
@nl
type
label
Hodgkin's lymphoma as a second cancer in multiple myeloma never exposed to lenalidomide.
@en
Hodgkin's lymphoma as a second cancer in multiple myeloma never exposed to lenalidomide.
@nl
prefLabel
Hodgkin's lymphoma as a second cancer in multiple myeloma never exposed to lenalidomide.
@en
Hodgkin's lymphoma as a second cancer in multiple myeloma never exposed to lenalidomide.
@nl
P2860
P1433
P1476
Hodgkin's lymphoma as a second cancer in multiple myeloma never exposed to lenalidomide
@en
P2093
Pak Tat Choi
Wai Ki Lee
P2860
P304
P356
10.1007/S00277-012-1639-3
P50
P577
2012-11-25T00:00:00Z